ArticleOncoimmunology

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

Emily M McWilliams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.